WHO ICTRP trial
After mapping of the axilla: radiotherapy or surgery
ISRCTN13672866 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN13672866 |
|---|---|
| Public title | After mapping of the axilla: radiotherapy or surgery |
| Scientific title | A phase III study comparing a complete axillary lymph node dissection with radiotherapy to the axilla in sentinel biopsy positive patients |
| Primary sponsor | European Organisation for Research and Treatment of Cancer (EORTC) (Belgium) |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase III |
| Countries | United Kingdom |
| Conditions | Topic: National Cancer Research Network; Subtopic: Breast Cancer; Disease: Breast Cancer Breast cancer |
| Interventions | Patients will be stratified by institution and will be randomised between complete axillary lymph node dissection and radiotherapy of the axilla. Follow up length: 5 years Study entry: single randomisation only |
| Registration date | Apr 29, 2010 |
| Target size | 600 |
| Secondary IDs | NCT00014612;1424; EORTC 10981-22023 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: